Journal of Allergy and Clinical Immunology-In Practice

Article	Citations
Cover 1	332
The Microbiome in Clinical Allergy and Immunology: Emerging Role as Friend and Foe	204
Predictors of Acute Care Reutilization in Pediatric Patients With Amoxicillin-Associated Reactions	154
Dupilumab and Eosinophils: A Red Flag?	154
Asthma and Comorbid Conditions	125
An Adolescent with Respiratory Distress	119
CME Exam: Emerging Systemic Therapeutic Biologics and Small Molecules for Atopic Dermatitis: How to Decide Which Treatment Is Right for Your Patients	115
Diagnosis and Management of Pollen Food Allergy Syndrome to Nuts	114
Targeting IL-5/5R for the treatment of idiopathic chronic eosinophilic pneumonia	111
A Diagnostic Approach to Gastrointestinal Symptoms in Patients with Common Variable Immunodeficiency	105
Patient perspectives on reproductive options for hereditary angioedema: A cross-sectional survey study	103
Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines	98
Application of passive monitoring of nighttime respiratory symptoms in chronic asthma management	93
Reply to “Peanut allergy prevention: A mother’s perspective”	89
Original Article Highlights From This Issue	89
Managing Atopic Dermatitis in Patients With Skin of Color	86
March 2023 Practice Notes	86
Disparities in Genetic Testing for Inborn Errors of Immunity	80
Oral Food Challenge Protocols in Food Protein-Induced Enterocolitis Syndrome: A Systematic Review	80
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study	79
Incidence of anaphylaxis in patients with alpha-gal syndrome receiving gelatin-containing vaccines: A large database analysis	77
Serum Sickness-Like Reactions in children taking antibiotics represent a distressing form of infection- associated urticaria and may recur unpredictably in susceptible children	73
A Guide to Pediatric Antibiotic Allergy Testing: A Report From the US Drug Allergy Registry	73
Cover 1	69
Table of Contents	65

Table of Contents	65
Leech-bite induced anaphylaxis with or without Hymenoptera venom sensitization	64
Respiratory Infections in Patients with Primary Immunodeficiency	63
Increased disinfectant use among adults with asthma in the era of COVID-19	61
FEF25-75% Is a More Sensitive Measure Reflecting Airway Dysfunction in Patients with Asthma: A Comparison Study Using FEF25-75% and FEV1%	61
A novel case discussion of pediatric lipid transfer protein syndrome	60
Nutritional treatment of atopic diseases according to YouTube videos	60
Immunodeficiency in 22q11.2 duplication syndrome	59
A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis	58
Real-world data are critical for the implementation of preschool food allergen immunotherapy	57
Information for Readers	56
A Case Study in Health Disparities: Barriers to Immunotherapy for Venom-Induced Anaphylaxis	56
Seeing the Forest for the Trees: Evaluating Population Data in Allergy-Immunology	54
Addressing the Social Determinants of Health Is Critical Even in Preschool-Age Children With Recurrent Wheezing	53
Practice Notes from the AAAAI	51
Information for Readers	51
An Updated Survey of SCID Outcomes Without Preconditioning Chemotherapy	51
Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease	50
Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80	50
Editorial Board	49
Information for Readers	49
Comparative Efficacy and Acceptability of Licensed Dose Second-Generation Antihistamines in Chronic Spontaneous Urticaria: A Network Meta-Analysis	48
Lone Ranger or Handpicked Posse? How Multidisciplinary Assessment Helps Evaluate Suspected Laryngeal Disorders	48
Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health	47
Placebo, Nocebo, and Patient Reported Outcome Measures in Drug Allergy	46
Perioperative Hypersensitivity Evaluation and Management: A Practical Approach	45
Editorial Board	45
Work and Asthma	45
Original Article Highlights From This Issue	45
Barriers to Timely Diagnosis of Eosinophilic Gastrointestinal Diseases	44
Analysis of spirometry measurements as predictors of aspirin desensitization outcomes	43
COVID-19 “infodemics” and asthmatic children: The return to school challenge	43
Original Article Highlights From This Issue	43
“Omalizumab plus”: Combining omalizumab with immunosuppression for treatment of refractory chronic urticaria: A multicenter UK series	43
Table of Contents	43
Table of Contents	43
Aspirin-Exacerbated Respiratory Disease: Association Between Patient-Reported Sinus and Asthma Morbidity	42
Breath-taking compliance: Does lower adherence translate to inferiority?	42
Early intervention in STAT3 dominant negative disease	42
December 2023 Practice Notes	42
Measuring Cough Severity: Time to Replace VAS With Patient Global Impression Scale?	42
Bronchodilator responsiveness is less common in allergic bronchopulmonary aspergillosis–complicating asthma than asthma alone	41
The Regulatory Environment of Telemedicine After COVID-19	41
Relationship of Reaction History to Positive Penicillin Skin Tests	41
CME Activities Calendar	40
Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate	40
CME Exam: Management of Severe Atopic Dermatitis in Pediatric Patients	40
Chronic Urticaria in Elderly—New Insights	40
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives	39
COVID-19 Treatments: Then and Now	39

Drug Allergy: Then, Now, and Next	39
Effective sirolimus treatment of 2 COPA syndrome patients	39
Information for Readers	38
Pruritic Papular Dermatitis From Bird Mites	38
When too much is too much	38
Original Article Highlights From This Issue	37
Continuous Rather Than Solely Early Farm Exposure Protects From Hay Fever Development	37
Overall Response to Anti-IL-5/Anti-IL5-Rα Treatment in Severe Asthma Does Not Depend on Initial Bronchodilator Responsiveness	36
Infant Exposure to Acid Suppressant Medications Increases Risk of Recurrent Wheeze and Asthma in Childhood	36
Prevention and Treatment of Asthma Exacerbations in Adults	36
Improvements in asthma control and quality of life with benralizumab are unrelated to baseline bronchodilator response	36
Olfactory Function Is Impaired in Patients with Mastocytosis	36
Clinical features and burden of genital attacks in hereditary angioedema	35
Future Directions of Allergen Immunotherapy for Allergic Rhinitis: Experts’ Perspective	35
Reply to “New aspects of fundamental pathology and environmental control: Important issues in allergic bronchopulmonary mycosis”	35
Infant Whole-Cell Versus Acellular Pertussis Vaccination in 1997 to 1999 and Risk of Childhood Hospitalization for Food-Induced Anaphylaxis: Linked Administrative Databases Cohort Study	35
Feeding difficulties in children with food protein–induced enterocolitis syndrome	34
The Debate: Regular Versus As-Needed Use of Intranasal Corticosteroids for a Patient-Centered Approach	34
Satisfaction with single maintenance and reliever therapy or as-needed combined inhaled corticosteroid-formoterol in adults with asthma	34
High SABA Using and Poor Asthma Control: Blaming Poor Adherence or Missing the Phenotype?	34
Macular Amyloidosis in an Atopic Patient After Aeroallergen Immunotherapy	34
Multifocal bronchial stenosis and extensive lobar atelectasis as a rare radiologic feature of severe eosinophilic asthma	34
The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis	34
Is More Documentation Better for Adverse Drug Reactions?	34
Vocal cord paralysis induced by oxaliplatin: Differential diagnosis of hypersensitivity	34
Prevalence and correlates of co-occurring allergies in a US food allergy patient registry	33
Quality and Safety: Learning from the Past and (Re)Imagining the Future	33
Editorial Board	33
Identification of motivators and barriers impacting successful food introduction or reintroduction after negative oral food challenges	33
Development of Food Allergy Data Dictionary: Toward a Food Allergy Data Commons	33
The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review	33
Disseminated BCG disease with defective immune metabolism caused by protein kinase C-delta deficiency	33
Electronic Cigarettes and Their Impact on Allergic Respiratory Diseases: A Work Group Report of the AAAAI Environmental Exposures and Respiratory Health Committee	33
Table of Contents	32
CME exam: A Sherlock Approach to a Kindred With a Variable Immunohematologic Phenotype	32
CME exam: Take a Leap of Faith: Implement Routine Genetic Testing in Your Office	32
CME exam: Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity	32
Original Article Highlights From This Issue	32
Reply to “Thoracic conidiobolomycosis: Invasive or allergic?”	31
Table of Contents	31
SARS-CoV-2 Vaccines: Where Are We Now?	31
Ask Not What AI Can Do to Us, but What We Can Do with AI	31
Cover 1	31
CME Exam: Biologics for the Use in Chronic Spontaneous Urticaria: When and Which	31
Editorial Board	31
Practice Notes from the AAAI	31
A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies	30
CME exam: Advances in the Understanding of Drug Hypersensitivity: 2012 Through 2022	30
Informing Risk Management for Patients With Cow’s Milk Allergy Based on Threshold Dose Distributions Using Low-Dose Food Challenges	30
Validation of the Urticaria Control Test (UCT) in Children With Chronic Urticaria	30
Reducing Health Disparities in Asthma: How Can Progress Be Made	30
Associations between employment and sociodemographic and health-related factors in asthmatic patients assessed at a regional severe asthma service	29
Utility of drug provocation tests in the evaluation of quinolone hypersensitivity reactions	29
The Role of Access and Cost-Effectiveness in Managing Asthma: A Systematic Review	29
Assessment of Real-World Escalation to Biologics in US Patients With Asthma	29
Practice Notes from the AAAI	29
Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use	29
Unraveling cephalosporin-associated anaphylaxis: A comprehensive analysis using FDA Adverse Event Reporting System data	29
Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting	29
One-Bag Desensitization Protocols in the Management of Chemotherapy Hypersensitivity	29
Dieting Resulting in Prurigo Pigmentosa (“Keto Rash”)	29
Cover 1	29
A Systematic Review of Patient-Reported Adherence Measures in Asthma: Which Questionnaire Is Most Useful in Clinical Practice?	29
Original Article Highlights From This Issue	28
Genomics Driving Diagnosis and Treatment of Inborn Errors of Immunity With Cancer Predisposition	28
Drug reaction with eosinophilia and systemic symptoms: Medication adherence and quality of life in survivors	28
Scratching the Itch: Managing Recurrent Pruritic Skin Conditions	28
Digital Antibiotic Allergy Decision Support Tool Improves Management of β-Lactam Allergies	28
Peanut allergen reaction thresholds during controlled food challenges in 2 Canadian randomized studies (Canada-ARM1 and PISCES)	28
Original Article Highlights From This Issue	28
Is anti-TPO IgG and total IgE clinically useful for the detection of autoimmune chronic spontaneous urticaria?	28
CME Exam: Respiratory Infections in Patients with Primary Immunodeficiency	28
Information for Readers	28
Mepolizumab-responsive Kimura disease	28
Acute At-Home Management of Anaphylaxis: 911: What Is the Emergency?	28
A low FEV1 confounds interpretation of FeNO as an eligibility criterion for dupilumab	28
CME Exam: Long-Term Respiratory Consequences of Early-Life Respiratory Viral Infections: A Pragmatic Approach to Fundamental Questions	28
Identification of EPX Variants in Human Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)	27
mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to pegaspargase	27
Predicting the natural development of peanut tolerance using longitudinal trajectories of peanut-specific serum IgE	27

Incident Asthma, Asthma Exacerbations, and Asthma-Related Hospitalizations in Patients With Atopic Dermatitis	27
Could Telemedicine Be Here to Stay? Understanding the Rapidly Changing Landscape of Telemedicine in Allergy and Immunology Practice	26
Chronic Urticaria and Angioedema: Masqueraders and Misdiagnoses	26
Effect of dupilumab treatment in a severe asthma patient with EGPA	26
Keeping Our Eyes on the Prize: Personalized and Precision Medicine With Biologics for Chronic Rhinosinusitis With Nasal Polyps	26
Maximizing the Potential of Vaccination	25
Cytokine Storm Syndromes in Pediatric Patients	25
March 2023 Practice Notes	25
Reduced Asthma Exacerbations by the Addition of Inhaled Corticosteroids to Rescue Therapy in Black and Latinx Adults	25
A case of dose-dependent Heiner syndrome	25
Giant Papillary Conjunctivitis Caused by a Fibroepithelial Polyp of the Lower Eyelid	25
Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines	24
Cephalexin, Cefaclor, and Ampicillin: Points in the Picture of β-Lactam Cross-Reactivity	24
Lenalidomide Desensitization for Delayed Cutaneous Reaction: A Case Series and Review of the Literature	24
Durability of penicillin allergy delabeling and post-testing penicillin utilization in adults with immune compromise	24
Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma	24
Neuropsychiatric Events Related to Montelukast and Pranlukast in Adults With Asthma and Rhinitis: A 10-Year Nationwide Population-Based Study	24
The Use of Albuterol/Budesonide as Reliever Therapy to Reduce Asthma Exacerbations	24
Low-level NLRP3 somatic mosaicism in adult-onset cryopyrin-associated periodic syndrome misdiagnosed as chronic urticaria	24
Hormonal Contraceptives Are Associated With an Increase in Incidence of Asthma in Women	24
Information for Readers	24
Child opportunity and outcomes in pediatric critical asthma: A multicenter analysis	24
Vitamin D Primary Prevention of Respiratory Infections and Asthma in Early Childhood: Evidence and Mechanisms	24
Leukotriene Receptor Antagonists and Risk of Neuropsychiatric Entities: A Meta-Analysis of Observational Studies	24
March 2023 Practice Notes	24
Risks of chronic urticaria after SARS-CoV-2 infection: Binational population-based cohort studies from South Korea and Japan	23
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis	23
Impulse oscillometry metrics identified preschool children at risk of future loss of lung function and asthma	23
Complement Genetics for the Practicing Allergist Immunologist: Focus on Complement Deficiencies	23
Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”	23
Ultrarush versus semirush venom immunotherapy: Outcome observations in real-world jack jumper ant cohort	23
Continuing Medical Education Calendar	23
Editorial Board	23
Continuing Medical Education Calendar	23
Reply to “How to deconstruct ‘race’ and spirometry”	23
Allergic Diseases and Mental Health	23
Factors associated with severe food protein-induced enterocolitis syndrome	23
May 2024 Practice Notes	23
Scratch pleasurability is high in chronic spontaneous urticaria	23
Cover 1	23
Not a Duck or a Rabbit: Asthma Control and Why Physician Perception Matters	22
Table of Contents	22
So How Should I Treat It? Campylobacter Infection in CVID and a Call for More Like This	22
Another Therapy for Chronic Rhinosinusitis With Nasal Polyps	22
Higher Risk of Hyperthyroidism in People with Asthma: Evidence from a Nationwide, Population-Based Cohort Study	22
Can You Teach an Old Drug New Tricks? The Use of Salbutamol for Gastrointestinal Anaphylaxis	22
Reply to “The forced renaissance of telemedicine during COVID-19: A fellow-in-training's perspective”	22
Original Article Highlights From This Issue	22
Cover 1	22
Reply to “Concerns about the approach of measuring allergens in early introduction foods for prevention of food allergy”	22
Reply to “Correspondence on ‘Artificial Intelligence Assesses Clinician’s Adherence to Asthma Guidelines Using Electronic Health Records’”	22
CME exam: Digital Inhalers and Remote Patient Monitoring for Asthma	22
Information for Readers	22
Generational Consequences From Historical Redlining: Longitudinal Impacts on Air Pollution and Asthma Health Outcomes	22
September 2023 Practice Notes	22
Successful SCID gene therapy in infant with disseminated BCG	22
Extreme Positive Patch Test Reaction to Ampicillin 30 Years After Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis	21
Asthma Phenotyping in Primary Care: Applying the International Severe Asthma Registry Eosinophil Phenotype Algorithm Across All Asthma Severities	21
Health-Related Quality of Life and Influencing Factors in Adults with Nonadvanced Mastocytosis—A Cross-Sectional Study and Qualitative Approach	21
Reply to “Both quality of life and exacerbation are important outcomes of work-related asthma”	21
Prevalence and risk associated with asthma in children hospitalized with SARS-CoV-2: a meta-analysis and systematic review	21
Refractory thoracic conidiobolomycosis treated with mepolizumab immunotherapy	21
Reply to “Intense allergic reactions to personalized oral immunotherapy treatments for food allergies at home”	21
Combining Allergen Components Improves the Accuracy of Peanut Allergy Diagnosis	21
Sensitization to trometamol in patients with delayed local reactions after administration of the Moderna mRNA-1273 vaccine against SARS-CoV-2	21
New Approaches to Food Allergy Immunotherapy	21
Two-step nonsteroidal anti-inflammatory drug challenges during pregnancy: A case series	21
Possible Protective Effect of Omalizumab on Lung Function Decline in Patients Experiencing Asthma Exacerbations	21
Managing CPAP Rhinitis	21
Allergic Rash Mimickers	21
Reply to “Does atopic dermatitis confer a clinically meaningful risk of cardiovascular disease?”	21
Tobacco Exposure and Efficacy of Biologic Therapy in Patients With Severe Asthma: A Nationwide Study From the Danish Severe Asthma Register	21
Perceptions on Home-Administration of Biologics in the Context of Severe Asthma: An International Qualitative Study	21
Table of Contents	21
Precautionary Allergen Labeling: What Advice Is Available for Health Care Professionals, Allergists, and Allergic Consumers?	20
Treatment of oral immunotherapy–associated eosinophilic esophagitis	20
Systematic Review of mHealth Applications That Interface with Inhaler Sensors in Asthma	20
Toolkit for Developing Structural Competency in Health Disparities in Allergy and Immunology Training and Research	20
Differentiating Between β-Lactam-Induced Serum Sickness–Like Reactions and Viral Exanthem in Children Using a Graded Oral Challenge	20
Persistent nivolumab-induced urticaria with vibratory and delayed-pressure angioedema	20
Inflammatory Markers to Inform Treatment of Asthma With Biologicals: FeNO Versus Blood Eosinophils	20
Management Strategies to Reduce Exacerbations in non-T2 Asthma	20
Pharmaceutical industry-sponsored meals and prescriptions of biologics for asthma	20
Cover 1	20
Examining Disparities in Pediatric Eosinophilic Esophagitis	20
Is Inhaler Technique Adequately Assessed and Reported in Clinical Trials of Asthma and Chronic Obstructive Pulmonary Disease Therapy? A Systematic Review and Suggested Best Practice Checklist	20
Moving FORWARD Toward Racial Equity in Food Allergy	20
Biologics for the Use in Chronic Spontaneous Urticaria: When and Which	20
Bronchodilator Responsiveness: An Underappreciated Biomarker for Asthma Exacerbations	20
All Physicians Have a Role in Advocating for Women’s Health	20
A Cost-Effectiveness Analysis of Epinephrine Autoinjector Risk Stratification for Patients with Food Allergy—One Epinephrine Autoinjector or Two?	20
Information for Readers	20
How to Measure Disease Activity, Impact, and Control in Patients with Recurrent Wheals, Angioedema, or Both	19
Recent Advances in the Treatment of Eosinophilic Esophagitis	19
Hypersensitivity to gadolinium-based contrast agents: A single-center retrospective analysis over 7 years	19